• DISTRIBUTION

  • INVESTMENT

  • DESIGN

  • MANUFACTURING

IT ALL COMES TOGETHER IN ONE PARTNERSHIP

CORE SERVICES

Design & Development

We will assist your projects through 1st & 2nd stage development stages including challenging validation & regolatory paths.

Investment

Our investment programs offer Technical and Venture capital assets at the most critical times in your developmental process.

Manufacturing

We offer both in-house and external manufacturing facilities with a specialist team of engineers and production support personnel.

China & AP Distribution

An already well-established distributor network in China and the Asia-Pacific region allows instant access into key global medical markets.

PROJECTS

  • img01

    Linear Cutter

    Lorem ipsum dolor sit amet, consectetur adipisicing elit.
  • img01

    Suction Irrigation

    Lorem ipsum dolor sit amet, consectetur adipisicing elit.
  • img01

    Endomagnetics

    Lorem ipsum dolor sit amet, consectetur adipisicing elit.
  • img01

    Cancer Therapy

    Lorem ipsum dolor sit amet, consectetur adipisicing elit.

NEWS

News Image
February 2017

TSALYS open Shenzhen office and Development Centre in Shenzhen, China

Read
News Image
January 2017

New Appointment - Senior Development Engineer

Read
News Image
June 2016

University of Shanghai for Science and Technology (USST) Strategic Alliance

Read

April 2016. Shanghai, China and Hong Kong

TSALYS Ltd, a leading Medical Device development, sales and marketing organisation, registered in Hong Kong and China announce the signing of a Strategic Alliance with the University of Shanghai for Science and Technology (USST).

The prime objective of alliance between these two leaders in their fields is to accelerate the research, development and application of innovation into the China and global Medical Device market.

Lee Edwards, Executive Chairman of TSALYS Ltd said…”We have long admired the research that Professor Song and his team at USST has undertaken. The challenge for institutions such as USST, and indeed for small most start-ups whether in China or abroad, is to transfer these concepts into commercially viable products. Finding the right partners, funding the increasingly challenging validation and regulatory paths and especially undertaking 2 nd Stage product and market development is something we have experience of…and can help practically. We are excited by this alliance and look forward working with Professor Song and his team at USST.”

Professor Chengli Song, Executive Director of the Shanghai Institute for Minimally Invasive Therapy based within the School of Biomedical Engineering at USST added “ As a leading academic institution we are dedicated to undertaking research into the advancement and development of Medical Devices that bring real benefits to patients….an Alliance with the team at TSALYS, who have unrivalled commercial and engineering experience in Medical Devices, both in China and abroad, is a great opportunity for us.